ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Long-Term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion

Wednesday, October 9, 2019

Submitted by

Mark Ferguson

Source

Source Name: JAMA Surgery

Source URL: https://jamanetwork.com/journals/jamasurgery/fullarticle/2752280?guestAccessKey=…

Author(s)

Chandima Divithotawela; Marcelo Cypel; Tereza Martinu; Lianne G. Singer; Matthew Binnie; Chung-Wai Chow; Cecilia Chaparro; Thomas K. Waddell; Marc de Perrot; Andrew Pierre; Kazuhiro Yasufuku; Jonathan C. Yeung; Laura Donahoe; Shaf Keshavjee; Jussi M. Tikkanen

Ex vivo lung perfusion was used in 25% of transplanted lungs in the Toronto program since 2008. This resulted in an increase in the number of transplanted patients without any degradation of long-term outcomes, including survival and freedom from chronic dysfunction.